Multimax® Beauty New Suite

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.001463.04.16
Date of registration and renewal:01.04.2016
Dosage form: & nbspTablets weighing 500 mg
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp Supplements containing zinc, copper, manganese Supplements containing iron Supplements containing chromium
Composition: & nbspDicalcium phosphate, ascorbic acid, calcium chloride, iron fumarate, E460, E570, DL-alpha tocopherol acetate, Ginkgo biloba powder, E464, U171, E1200, E1518, E1521, E132, E110, E129, zinc oxide, magnesium oxide, nicotinamide, E551, mineral premix (sodium molybdate, sodium selenate, chromium choride, metavanadate, silicon dioxide), manganese sulfate, phytomenadione 1%, calcium pantothenate, retinol acetate, E468, E470, copper oxide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride, biotin 1%, sodium selenate, potassium iodide, lutein 5%, cholecalciferol, cyanocobalamin, folic I acid.
Scope: & nbspFor the realization of the supplementary source of vitamins A, Bl, B2, B6, B12, C, D, E, PP, K1, pantothenic acid, biotin, folic acid, zinc, iodine, manganese as an biologically active food additive (ANNEX) , iron, selenium, copper, molybdenum, chromium, vanadium, a source of flavonoids.
Suggested Usage: & nbspAdults take 1 tablet a day with meals. Duration of admission is 2-3 weeks.
Contraindications:Individual intolerance to the components of the product, pregnancy, breast-feeding. Before use, it is recommended to consult a doctor.Persons with thyroid disease should consult an endocrinologist.
Shelf life:3 years.
Storage conditions:Keep in a dry place, protected from direct sunlight and out of reach of children, at a temperature not exceeding + 30 ° C.
Research protocols:Expert conclusion of the FBUC of the Federal Target Program of the Federal Service for Supervision of Consumer Rights Protection of the Russian Federation No. 10-2FTS / 159 of March 17, 2016.
Recipient:Unifarm Inc., Representative Office of the Corporation (USA)Unifarm Inc., Representative Office of the Corporation (USA) Russia
Information update date: & nbsp08.01.2017
Instructions
Up
talkdrugs

+8 (800)555-35-35

[email protected]

The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

It is forbidden to copy any instructions of medicinal products, biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

All rights reserved.© Publishing group "GEOTAR-Media" 2008-2016.